BPC-157 in Research: Material Properties, Documentation Standards, and Canadian Sourcing
BPC-157 is one of the most frequently searched research peptides in Canada. This article provides an overview of the material's structural characteristics, the analytical methods used to verify it, and what researchers should consider when sourcing it from Canadian suppliers.
This material is for research use only and is not intended for human or animal use.
What Is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a chain of 15 amino acids derived from a region of the human gastric juice protein BPC. Its molecular formula is C₆₂H₉₈N₁₆O₂₂ and its molecular weight is approximately 1419.5 Da.
It is a stable, water-soluble peptide that is typically produced in lyophilized (freeze-dried) form for research applications. As a lyophilized powder, it maintains structural integrity under appropriate storage conditions, which generally include storage at −20°C and protection from moisture.
BPC-157 does not appear in standard pharmacopoeial monographs. It is a synthetic research compound, not an approved pharmaceutical, and its study in Canada falls outside clinical or therapeutic contexts.
Research Context
BPC-157 appears in the scientific literature primarily in connection with in vitro and animal model studies. Published research has examined it in contexts including:
- Tissue and wound healing models
- Gastrointestinal mucosal protection studies
- Tendon and bone repair models
- Neurological and vascular models
This body of research is preclinical. There are no approved clinical applications for BPC-157, and it is not authorized for human or veterinary use in Canada.
Researchers sourcing BPC-157 should apply it exclusively within the scope of qualified laboratory and analytical work.
Analytical Verification: What Matters
For a research material to be usable with confidence, two properties must be independently verified: identity and purity.
Identity Verification
Identity confirmation establishes that the material in the vial is what its label states. For BPC-157, this is typically accomplished through:
- Liquid chromatography–mass spectrometry (LC-MS): Confirms molecular weight and fragmentation pattern consistent with the expected peptide sequence.
- Amino acid analysis: Verifies the residue composition matches BPC-157.
Identity cannot be inferred from purity alone. A highly pure compound can still be mis-identified if identity was never independently confirmed.
Purity Testing
Purity is most commonly assessed by:
- Reverse-phase HPLC (RP-HPLC): Separates the compound from related impurities and expresses the target compound as a percentage of the total detected area. Reported as HPLC purity (e.g., ≥98%).
- UV detection at 220 nm is standard for peptide bonds.
A purity result is only meaningful when it is tied to a specific batch. Catalogue-level purity claims — those that apply generally to a product line rather than a verified lot — should not be treated as batch verification.
What to Request from a Supplier
When sourcing BPC-157 in Canada, researchers should request:
- A Certificate of Analysis (CoA) with a traceable lot number
- Confirmation of the analytical method used for identity (not purity alone)
- Confirmation of the analytical method used for purity
- The date of analysis and name of the testing laboratory
If any of these are absent or cannot be provided, the documentation does not meet the standard required to verify material quality for research use.
Storage and Handling
Lyophilized BPC-157 should be stored at −20°C in a dry environment, away from light and moisture. Once reconstituted, it should be aliquoted and used promptly or stored at −80°C for short-term use. Repeated freeze-thaw cycles degrade peptide integrity.
These are general research handling guidelines. Researchers should consult their institution's standard operating procedures for peptide handling.
Sourcing in Canada
Demand for BPC-157 in Canada has grown substantially. Search data from early 2026 shows the keyword "bpc-157 canada" generating significant monthly volume, reflecting growing interest from the research community.
When evaluating Canadian suppliers:
- Confirm the supplier explicitly scopes materials for research use only, with no human or clinical use claims
- Verify that batch-level documentation is available — not just catalogue-level claims
- Check whether the supplier distinguishes between their quality framework and the manufacturer's own records
- Confirm that the certificate of analysis is tied to the lot you are ordering, not a historical lot used as a standing reference
Suppliers who do not make these distinctions are applying a lower standard than the material's research use demands.
Summary
| Property | Detail |
|---|---|
| Molecular formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular weight | ~1419.5 Da |
| Sequence length | 15 amino acids |
| Presentation | Lyophilized powder |
| Storage | −20°C, dry, protected from light |
| Identity method | LC-MS or amino acid analysis |
| Purity method | RP-HPLC |
| Regulatory status (Canada) | Not approved for human or animal use |
BPC-157 is available through Elysium Bio Labs as a lyophilized research material for qualified laboratory and analytical applications. All materials are presented for research use only and are not intended for human or animal use. Documentation is published at the batch level when verified records are available.
